跳至主要内容
临床试验/NCT02704689
NCT02704689终止不适用

A Prospective Multi-Center Evaluation of a Hydraulic Expandable TLIF Cage for the Treatment of Degenerative Disc Disease of the Lumbar Spine

Stryker Spine2 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2016年6月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
9
试验地点
2
主要终点
Post-operative Radiographic Measurements to Evaluate Segmental Lordosis as Measured by Degree of Change From Pre-operative X-rays.

研究概览

简要总结

This is a post-market clinical study of the AccuLIF expandable transforaminal lumbar interbody fusion (TLIF) cage in patients requiring surgery for degenerative disc disease (DDD) with up to Grade I spondylolisthesis or retrolisthesis, at one or two levels, between L2 and S1.

详细描述

Study evaluations will be evaluated pre-operatively and at 6-weeks, 3-months, 6-months, 12-months and 24-months post-operatively to assess clinical outcomes, patient reported outcomes and radiographic status.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is skeletally mature and between 18 and 70 years of age.
  • DDD and up to Grade I spondylolisthesis or retrolisthesis, requiring decompression and arthrodesis at one or two contiguous levels between L2 and S
  • No previous surgery at the same or adjacent level (other than microdiscectomy / laminectomy) at the same or adjacent level.
  • Non-responsive to conservative (non-surgical) treatment for back pain for a minimum of 6 months.
  • Subject understands the conditions of enrollment and is willing to sign and date the Informed Consent.
  • Subject agrees to comply with visit schedule and completing study questionnaires.

排除标准

  • Significant instability of the spine.
  • Requires TLIF at more than 2 levels between L2 and S
  • Previously undergone lumbar spine surgery (other than microdiscectomy / laminectomy) at the same or adjacent level.
  • Younger than 18 years of age, or older than 70 years of age.
  • BMI of 40 or greater.
  • History of metabolic bone disease
  • Osteoporosis
  • Diabetes mellitus requiring daily insulin management.
  • Subject has any of the following:
  • Progressive neuromuscular disease; OR
  • Autoimmune disease; OR
  • Active malignancy within the last 15 years; OR
  • Active hepatitis; OR
  • AIDS, ARC, or is HIV positive; OR
  • Syringomyelia at any spinal level; OR
  • Any other condition that would interfere with the subject self -assessment of pain, function or quality of life.
  • Allergy to implant materials (titanium, titanium alloy).
  • Active systemic infection or infection localized to the site of implantation.
  • Primary or metastatic tumors involving the spine.
  • Open wounds or inadequate issue tissue coverage over the operative site.
  • History of significant mental illness or mental incapacity.
  • Pregnancy or intent to become pregnant.
  • Participating in another investigational study for a similar purpose.
  • Belongs to a vulnerable population that would compromise ability to provide informed consent or compliance with follow-up requirements.
  • Smokers unwilling to cease up to 3 months post-op or recent history of alcohol or other substance abuse within the past 2 years.
  • Workers compensation.

研究组 & 干预措施

AccuLIF

Experimental

干预措施: AccuLIF expandable TLIF cage (Device)

结局指标

主要结局

Post-operative Radiographic Measurements to Evaluate Segmental Lordosis as Measured by Degree of Change From Pre-operative X-rays.

时间窗: 24 months

Post-operative radiographic measurements to evaluate segmental lordosis as measured by degree of change from pre-operative x-rays.

Pre-operative Comparison to Post-operative Radiographic Outcomes of Disc Height as Measured in mm.

时间窗: 24 months

Pre-operative comparison to post-operative radiographic outcomes of disc height as measured in mm.

次要结局

  • Medical Outcomes: Incidence of Complications Associated With the Procedure and/or Device.(24 months)
  • Surgical Outcomes: To Evaluate the Length of Time Hospitalized for the Index Procedure as Measured in Days.(Peri-op)
  • Patient Reported Outcomes: Oswestry Disability Index Measurements for Comparison of Pre-operative to Post-operative Evaluations.(24 months)
  • Patient Reported Outcomes: Evaluations of Quality of Life (QOL) as Measured by the SF-12.(24 months)
  • Radiographic Outcomes: Fusion Status Evaluated by X-ray and/or CT Assessments.(24 months)
  • Radiographic Outcomes: Device Placement Status as Evaluated by X-ray and/or CT Imaging.(24 months)
  • Surgical Outcomes: To Measure the Amount of Blood Loss at the Time of Surgery.(Operative Visit)
  • Surgical Outcomes: To Measure the Length of Surgery as Measured in Time of Surgery Duration.(Operative Visit)
  • Medical Outcomes: Comparison of Pre-operative Neurological Reflex Evaluations in the Lower Extremities to Post-operative Findings(24 months)
  • Medical Outcomes: Comparison of Pre-operative Neurological Sensory Responses in the Lower Extremities to Post-operative Findings.(24 months)
  • Medical Outcomes: Comparison of Pre-operative Neurological Motors Assessments Evaluated by Straight Leg Raise, Femoral Stretch, and Strength Assessments, to Post-operative Findings.(24 months)
  • Patient Reported Outcomes: Comparison of Pre-operative Back Pain Scores to Post-operative Levels as Measured by the (Visual Analog Scale (VAS).(24 months)

研究者

发起方
Stryker Spine
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验